Why the study?
What are the pharmacologic considerations in the management of acute coronary syndrome in elderly patients?
What are the pharmacologic considerations in the management of acute coronary syndrome in elderly patients?
Answers are grounded in this paper and cite their sources.
Highlights the underrepresentation of elderly patients in ACS clinical trials and discusses pharmacologic management considerations.
Despite having a high prevalence of acute coronary syndromes (ACS) and higher ACS related mortality rates than younger patients, elderly patients are often underrepresented in ACS clinical trials. ...
No takes yet. Share an insight, caveat, or question.
Martinez et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: